NOVO
Live / Registered — Registered — Section 71 accepted (as of 10 Feb 2025)
What this means for you
Registered since 19 Jun 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79214800
- Registration number
- 5494605
- Mark type
- Stylized text
- Filed
- 21 Apr 2017
- Published for opposition
- 03 Apr 2018
- Registered
- 19 Jun 2018
- Attorney of record
- /Spencer Beall/
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of diabetes, obesity, cardiovascular diseases, endocrine diseases and disorders, hormonal diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, and blood disorders
Owner
- Novo Nordisk A/S, Bagsvaerd, DK
- Novo Nordisk A/S, DK
- Novo Nordisk A/S, DK
Prosecution history
- 10 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 10 Feb 2025 — REGISTERED-SEC.71 ACCEPTED
- 10 Feb 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 20 Aug 2024 — TEAS SECTION 71 RECEIVED
- 19 Jun 2023 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 12 Oct 2018 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 22 Sept 2018 — FINAL DISPOSITION NOTICE SENT TO IB
- 22 Sept 2018 — FINAL DISPOSITION PROCESSED
- 19 Sept 2018 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 19 Jun 2018 — REGISTERED-PRINCIPAL REGISTER
- 03 Apr 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Apr 2018 — PUBLISHED FOR OPPOSITION
- 14 Mar 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Mar 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Jan 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED